GOVX (GeoVax Labs, Inc.) Short-Term Debt to Capital
GeoVax Labs, Inc. (GOVX) is a reputable developer of immune therapies for oncology and dangerous infections that has created effective gene data delivery systems. The US-based company relies on innovative viral vectors and government support. This debt-to-equity chart shows a value of 0.10. Meanwhile, the business is subject to significant binary risks due to its narrow specialization and dependence on external grants.
Analytical breakdowns for GeoVax Labs, Inc.
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
- company profitability and valuation multiples indicators:
Fundamental valuation:GeoVax Labs Inc
This ratio compares liabilities with a maturity of up to one year against equity, allowing for an assessment of the risk of cash flow gaps and the overall debt load. By analyzing the dynamics of the ratio between short-term liabilities and equity, investors determine the financial stability of GeoVax Labs, Inc. (GOVX) during periods of awaiting government grants and the completion of clinical trials for cancer and infection vaccines.
Main competitors
Short-Term Debt to Capital ARGX|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ABVX (Abivax Pharma)|Short-Term Debt to Capital admabiologics.com ADMA|PTGX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital IMVT (Immunovant Inc)|Kiniksa Pharmaceuticals Ltd (KNSA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Grifols Biemat|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital celldex.com|Short-Term Debt to Equity Ratio AUPH (Aurinia Pharmaceuticals Inc.)|BCRX (BioCryst Pharmaceuticals, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VERA (Vera Pharma)|Short-Term Debt to Capital Coefficient Dianthus Corp (DNTH)|PHVS - Short-Term Debt to Equity|AbCellera Biologics Inc (ABCL) - Short-Term Debt to Equity Ratio|Tourmaline Bio (TRML) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Precigen Inc|Short-Term Debt to Equity Ratio PHAR|Short-Term Debt to Capital Nektar Corp|Short-Term Debt to Equity Upstream Bio Inc (UPB)|zenasbio.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital IMNM (Immunome)|Gossamer Bio Inc (GOSS) - Current Liabilities to Capital|KalVista Pharmaceuticals Inc - Short-Term Debt to Capital|Short-Term Indebtedness to Equity Septerna Pharma (SEPN)|PVLA: Short-Term Debt to Capital|Current Liabilities to Capital savarapharma.com (SVRA)|Short-Term Debt to Equity Rigel Pharmaceuticals, Inc.|Current Liabilities to Capital AnaptysBio Inc ANAB|Short-Term Debt to Equity Ratio ATXS (Astria Pharma)|Short-Term Debt to Equity ENGN (enGene Corp)|Short-Term Debt to Capital RAPT (RAPT Therapeutics)|Short-Term Debt to Capital Aerovate Therapeutics, Inc. JBIO|ACRS: Short-Term Debt to Equity Ratio|KYTX (Kyverna Therapeutics Inc.) - Short-Term Debt to Capital Ratio|TLSA (Tiziana Life Sciences PLC) - Short-Term Debt to Equity Ratio|Cabaletta Bio Inc - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Ventyx Biosciences|Short-Term Debt to Equity THTX|Short-Term Debt to Capital AVTX|Short-Term Debt to Capital Eledon Pharmaceuticals Inc. (ELDN)|Short-Term Debt to Capital AGEN (Agenus Inc)|Climb Bio, Inc - Short-Term Debt to Equity|ZURA - Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient atyrpharma.com ATYR|ADAG (adagene.com) - Short-Term Debt to Equity Ratio|Ikena Oncology - Ratio of Short-Term Indebtedness to Capital|STTK (Shattuck Labs Inc) - Short-Term Debt to Capital|Equillium Bio (EQ) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Connect Biopharma (CNTB)|immunic-therapeutics.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital ATRA (Atara Bio)|IFRX - Short-Term Debt to Equity Ratio|XFOR: Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Coefficient Adicet Bio ACET|CELU: Short-Term Debt to Capital|Short-Term Indebtedness to Equity inmunebio.com INMB|Short-Term Debt to Equity Barinthus Biotherapeutics plc|Current Liabilities to Capital Kezar Life Sciences Inc. KZR|Short-Term Debt to Equity Ratio SABS (SAB Biotherapeutics, Inc)|Short-Term Debt to Equity AKTX (Akari Therapeutics, Plc)|Enlivex Therapeutics Ltd. - Short-Term Debt to Equity Ratio|QTTB: Short-Term Debt to Capital Ratio|EDSA - Short-Term Debt to Equity|Current Liabilities to Equity IBIO|CARM: Short-Term Debt to Capital|XTL Bio - Ratio of Short-Term Indebtedness to Capital|BOLT (Bolt Biotherapeutics Inc.) - Short-Term Debt to Capital|Short-Term Debt to Capital HCW Biologics Inc|Short-Term Debt to Equity Aptevo Therapeutics (APVO)|AIM (aimimmuno.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Aditxt, Inc. ADTX|GRI - Short-Term Debt to Equity Ratio|XORTX Therapeutics Inc. - Short-Term Debt to Capital|HIND - Short-Term Debt to Capital|REVB (Revelation Biosciences, Inc.) - Short-Term Debt to Equity Ratio|Indaptus Therapeutics Inc - Ratio of Short-Term Indebtedness to Capital|SCNI (Scinai) - Short-Term Debt to Capital|CalciMedica Corp (CALI) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Affimed (AFMD)|Short-Term Debt to Equity Ratio allakos.com ALLK|Short-Term Debt to Equity HOOKIPA Pharma HOOK|IGMS - Short-Term Debt to Equity Ratio|ITOS: Short-Term Debt to Equity Ratio|OCEA - Short-Term Debt to Capital|TC Biopharm (TCBP) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio THRD